Non-inferiority of dose reduction versus standard dosing of TNF-inhibitors in axial spondyloarthritis.

Jordi GratacósCaridad PontesXavier JuanolaJesús SanzFerran TorresCristina AvendañoAntoni VallanoGonzalo CalvoEugenio de MiguelRaimon Sanmartínull null

Published in: Arthritis research & therapy (2019)

EU Clinical Trials Registry, EudraCT 2011-005871-18 and ClinicalTrials.gov, NCT01604629 .

Keyphrases

clinical trial
rheumatoid arthritis
disease activity
ankylosing spondylitis
phase ii
open label
study protocol
phase iii
double blind